TWI413522B - 苯并二氮呯化合物及藥學組成物 - Google Patents

苯并二氮呯化合物及藥學組成物 Download PDF

Info

Publication number
TWI413522B
TWI413522B TW098105587A TW98105587A TWI413522B TW I413522 B TWI413522 B TW I413522B TW 098105587 A TW098105587 A TW 098105587A TW 98105587 A TW98105587 A TW 98105587A TW I413522 B TWI413522 B TW I413522B
Authority
TW
Taiwan
Prior art keywords
ethyl
group
pyridin
dione
diazepine
Prior art date
Application number
TW098105587A
Other languages
English (en)
Chinese (zh)
Other versions
TW200940067A (en
Inventor
Kunio Oshima
Takashi Oshiyama
Shinichi Taira
Yasuhiro Menjo
Hokuto Yamabe
Shuuji Matsumura
Masataka Ueda
Yasuo Koga
Kuninori Tai
Sunao Nakayama
Toshiyuki Onogawa
Kenji Tsujimae
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of TW200940067A publication Critical patent/TW200940067A/zh
Application granted granted Critical
Publication of TWI413522B publication Critical patent/TWI413522B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW098105587A 2008-02-22 2009-02-20 苯并二氮呯化合物及藥學組成物 TWI413522B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008041296 2008-02-22
JP2008227368 2008-09-04

Publications (2)

Publication Number Publication Date
TW200940067A TW200940067A (en) 2009-10-01
TWI413522B true TWI413522B (zh) 2013-11-01

Family

ID=40600203

Family Applications (1)

Application Number Title Priority Date Filing Date
TW098105587A TWI413522B (zh) 2008-02-22 2009-02-20 苯并二氮呯化合物及藥學組成物

Country Status (26)

Country Link
US (2) US8338406B2 (enExample)
EP (1) EP2254873B1 (enExample)
JP (1) JP5355582B2 (enExample)
KR (1) KR101332948B1 (enExample)
CN (2) CN101952259B (enExample)
AR (1) AR070449A1 (enExample)
AU (1) AU2009216079B2 (enExample)
BR (1) BRPI0908132A2 (enExample)
CA (1) CA2715872A1 (enExample)
CO (1) CO6300950A2 (enExample)
CY (1) CY1115220T1 (enExample)
DK (1) DK2254873T3 (enExample)
ES (1) ES2494366T3 (enExample)
HR (1) HRP20140796T1 (enExample)
IL (1) IL207276A (enExample)
MX (1) MX2010009269A (enExample)
MY (1) MY156226A (enExample)
NZ (1) NZ587157A (enExample)
PL (1) PL2254873T3 (enExample)
PT (1) PT2254873E (enExample)
RU (1) RU2496775C2 (enExample)
SI (1) SI2254873T1 (enExample)
TW (1) TWI413522B (enExample)
UA (1) UA103018C2 (enExample)
WO (1) WO2009104819A1 (enExample)
ZA (1) ZA201005469B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2254873B1 (en) 2008-02-22 2014-06-04 Otsuka Pharmaceutical Co., Ltd. Benzodiazepine compound and pharmaceutical composition
TWI481601B (zh) * 2009-08-21 2015-04-21 Otsuka Pharma Co Ltd 含氮化合物及藥學組成物
US8796447B2 (en) 2009-08-21 2014-08-05 Otsuka Pharmaceutical Co., Ltd. Process for producing benzo[B][1,4]diazepine-2,4-dione compound
JP2012184225A (ja) * 2011-02-18 2012-09-27 Otsuka Pharmaceut Co Ltd 医薬組成物
CA2834548C (en) 2011-04-28 2021-06-01 The Broad Institute, Inc. Inhibitors of histone deacetylase
AR090037A1 (es) 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
EP2780344A1 (en) 2011-11-15 2014-09-24 Xention Limited Thieno [2, 3 - c]pyrazoles for use as potassium channel inhibitors
WO2014018979A1 (en) 2012-07-27 2014-01-30 The Broad Institute, Inc. Inhibitors of histone deacetylase
WO2014100438A1 (en) 2012-12-20 2014-06-26 The Broad Institute, Inc. Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
JOP20190086A1 (ar) * 2016-10-21 2019-04-18 Novartis Ag مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب
EA038455B1 (ru) * 2016-10-26 2021-08-31 Новартис Аг Новые производные нафтиридинона и их применение в лечении аритмии
SG11202002032SA (en) 2017-09-22 2020-04-29 Jubilant Epipad LLC Heterocyclic compounds as pad inhibitors
CN111225915B (zh) 2017-10-18 2023-03-07 朱比兰特埃皮帕德有限公司 作为pad抑制剂的咪唑并吡啶化合物
AU2018362046B2 (en) 2017-11-06 2023-04-13 Jubilant Prodel LLC Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation
AU2018372211B2 (en) 2017-11-24 2023-02-02 Jubilant Episcribe LLC, Heterocyclic compounds as PRMT5 inhibitors
CA3125731A1 (en) 2018-01-12 2019-07-18 KDAc Therapeutics, Inc. Combination of a selective histone deacetylase 3 (hdac3) inhibitor and an immunotherapy agent for the treatment of cancer
CA3093527A1 (en) 2018-03-13 2019-09-19 Jubilant Prodel LLC Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040655A1 (en) * 1995-06-07 1996-12-19 Merck & Co., Inc. Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3y l)-3-amides

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133056A (en) 1961-05-15 1964-05-12 May & Baker Ltd N-phenylpiperazine derivatives of tetrahydrobenzodiazepines
BE707667A (enExample) 1966-12-14 1968-06-07
US3984398A (en) 1966-12-14 1976-10-05 Roussel-Uclaf 1,5-Benzodiazepine-2,4-diones
US4001408A (en) 1966-12-14 1977-01-04 Roussel-Uclaf Substituted heterocyclic compounds, processes and composition including those
JPH0296133A (ja) * 1988-10-01 1990-04-06 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料
BR9200951A (pt) 1991-03-21 1992-11-17 Hoffmann La Roche Compostos, processo para sua producao,preparacoes farmaceuticas e uso
US5428031A (en) * 1991-12-03 1995-06-27 Merck & Co., Inc. Methods of treating cardiac arrhythmia
US5700797A (en) 1995-06-07 1997-12-23 Merck & Co, Inc. N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides
GB0008179D0 (en) 2000-04-05 2000-05-24 Glaxo Group Ltd Chemical process
AU6895000A (en) 1999-08-09 2001-03-05 Merck & Co., Inc. Antiarrhythmic compounds
ES2309209T3 (es) * 2001-11-13 2008-12-16 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. 1,4-benzodiazepinas sustituidas y uso de las mismas para el tratamiento del cancer.
AU2003297398B2 (en) 2002-12-20 2009-09-24 Amgen Inc. Asthma and allergic inflammation modulators
TWI329641B (en) 2005-08-31 2010-09-01 Otsuka Pharma Co Ltd (benzo[b]thiophen-4-yl)piperazine compounds, pharmaceutical compositions comprising the same, uses of the same and processes for preparing the same
JP4785881B2 (ja) * 2007-02-27 2011-10-05 大塚製薬株式会社 医薬
EP2254873B1 (en) 2008-02-22 2014-06-04 Otsuka Pharmaceutical Co., Ltd. Benzodiazepine compound and pharmaceutical composition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040655A1 (en) * 1995-06-07 1996-12-19 Merck & Co., Inc. Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3y l)-3-amides

Also Published As

Publication number Publication date
ES2494366T3 (es) 2014-09-15
CN101952259A (zh) 2011-01-19
HRP20140796T1 (hr) 2014-10-24
ZA201005469B (en) 2011-11-30
TW200940067A (en) 2009-10-01
CA2715872A1 (en) 2009-08-27
UA103018C2 (uk) 2013-09-10
DK2254873T3 (da) 2014-06-30
PT2254873E (pt) 2014-08-29
US8664217B2 (en) 2014-03-04
PL2254873T3 (pl) 2014-10-31
RU2496775C2 (ru) 2013-10-27
EP2254873A1 (en) 2010-12-01
SI2254873T1 (sl) 2014-07-31
CN103554088A (zh) 2014-02-05
KR101332948B1 (ko) 2014-01-17
IL207276A0 (en) 2010-12-30
BRPI0908132A2 (pt) 2015-08-04
NZ587157A (en) 2012-05-25
WO2009104819A1 (en) 2009-08-27
JP5355582B2 (ja) 2013-11-27
CO6300950A2 (es) 2011-07-21
MX2010009269A (es) 2010-09-14
AU2009216079A1 (en) 2009-08-27
AR070449A1 (es) 2010-04-07
US20100331317A1 (en) 2010-12-30
IL207276A (en) 2014-11-30
AU2009216079B2 (en) 2013-08-22
MY156226A (en) 2016-01-29
CN103554088B (zh) 2016-02-24
US8338406B2 (en) 2012-12-25
HK1145461A1 (en) 2011-04-21
US20130040941A1 (en) 2013-02-14
JP2011512324A (ja) 2011-04-21
EP2254873B1 (en) 2014-06-04
RU2010138928A (ru) 2012-03-27
KR20100124781A (ko) 2010-11-29
CN101952259B (zh) 2013-07-03
CY1115220T1 (el) 2017-01-04

Similar Documents

Publication Publication Date Title
TWI413522B (zh) 苯并二氮呯化合物及藥學組成物
US9212187B2 (en) Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
JP2012184225A (ja) 医薬組成物
EP3741752A1 (en) Tam family kinase /and csf1r kinase inhibitor and use thereof
JP5669481B2 (ja) 医薬組成物
HK1145461B (en) Benzodiazepine compound and pharmaceutical composition
HK40016947B (en) Anti-fibrotic pyridinones
HK1167391B (en) Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees